Amount of equity interest received on disposal of discontinued operation

No definition available.

Name:	adxn_AmountOfEquityInterestReceivedOnDisposalOfDiscontinuedOperation
Namespace Prefix:	adxn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Cost of accelerated vesting of equity incentive units of employees transferred

+ References

No definition available.

+ Details

Name:	adxn_CostOfAcceleratedVestingOfEquityIncentiveUnitsOfEmployeesTransferred
Namespace Prefix:	adxn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Cost of legal fees for disposal of discontinued operations

+ References

No definition available.

+ Details

Name:	adxn_CostOfLegalFeesForDisposalOfDiscontinuedOperations
Namespace Prefix:	adxn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of consideration for disposal of discontinued operations.

+ References

No definition available.

+ Details

Name:	adxn_DisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsConsideration
Namespace Prefix:	adxn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of costs related to disposal of discontinued operations.

+ References

No definition available.

+ Details

Name:	adxn_DisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsCosts
Namespace Prefix:	adxn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of other consideration for disposal of discontinued operations.

+ References

No definition available.

+ Details

Name:	adxn_DisposalOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsOtherConsideration
Namespace Prefix:	adxn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Fair value of service agreement included in calculation of gain or loss on transaction

+ References

No definition available.

+ Details

Name:	adxn_FairValueOfServiceAgreementIncludedInCalculationOfGainOrLossOnTransaction
Namespace Prefix:	adxn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of gain (loss), net of tax on discontinuance when operations are discontinued.

+ References

No definition available.

+ Details

Name:	adxn_GainLossOnDiscontinuanceNetOfTax
Namespace Prefix:	adxn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Gross proceeds from disposal of discontinued operation

+ References

No definition available.

+ Details

Name:	adxn_GrossProceedsFromDisposalOfDiscontinuedOperation
Namespace Prefix:	adxn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of investment in divestment company.

+ References

No definition available.

+ Details

Name:	adxn_InvestmentInDivestmentCompany
Namespace Prefix:	adxn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Net debt liabilities related to divested company

+ References

No definition available.

+ Details

Name:	adxn_NetDebtLiabilitiesRelatedToDivestedCompany
Namespace Prefix:	adxn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of net gain on derecognition of divestment company.

+ References

No definition available.

+ Details

Name:	adxn_NetGainOnDivestmentCompanyDerecognition
Namespace Prefix:	adxn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Percentage of equity interest received

+ References

No definition available.

+ Details

Name:	adxn_PercentageOfEquityInterestReceived
Namespace Prefix:	adxn_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Retirement benefit obligation of employees leaving due to disposal of discontinued operation

+ References

No definition available.

+ Details

Name:	adxn_RetirementBenefitObligationOfEmployeesLeavingDueToDisposalOfDiscontinuedOperation
Namespace Prefix:	adxn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 5
-IssueDate 2025-01-01
-Paragraph 33
-Subparagraph b
-Clause iii
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_b_iii&doctype=Standard
-URIDate 2025-03-27

+ Details

Name:	ifrs-full_GainLossRecognisedOnMeasurementToFairValueLessCostsToSellOrOnDisposalOfAssetsOrDisposalGroupsConstitutingDiscontinuedOperation
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	ifrs-full_SignificantInvestmentsInAssociatesAxis=adxn_NeurosterixUsHoldingsLlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_ContinuingAndDiscontinuedOperationsAxis=adxn_AllostericModulatorDrugDiscoveryTechnologyPlatformAndPortfolioOfPreclinicalProgramsDisposalGroupDiscontinuedOperationsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Discontinued operations - Details of the net gain of the sale of activities (Details) - CHF (SFr)		12 Months Ended		24 Months Ended
	Apr. 02, 2024	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2025
Neurosterix US Holdings LLC
Disclosure
Percentage of equity interest received	20.00%
Discontinued operations as disclosed below
Disclosure
Cash in from Neurosterix Pharma Sarl sale	SFr 5,000,000		SFr 5,000,000	SFr 5,000,000
Fair value of Neurosterix US Holdings LLC's participation	SFr 9,420,000		9,428,400	9,400,000
Net gain on Neurosterix Pharma Sarl derecognition (IFRS 10)			539,250
Retirement benefit obligation of employees leaving the Group (IAS 19)			433,791
Fair value of service agreement			182,348
Net debt liabilities related to Neurosterix Pharma Sarl (IFRS 16)			11,144
Other consideration		SFr 114,342
Total disposal consideration		114,342	15,594,933
Investment in Neurosterix Pharma Sarl			(20,000)
Legal fees paid for Neurosterix Transaction			(473,269)
Accelerating vesting ESOP/DSPPP			(1,158,069)
Total costs related to activities sold			(1,651,338)
Net gain on sale before income tax		114,342	13,943,595
Net gain on sale after income tax		SFr 114,342	SFr 13,943,595	SFr 14,100,000
Discontinued operations as disclosed below \| Neurosterix US Holdings LLC
Disclosure
Percentage of equity interest received	20.00%		20.00%